R21AI078834/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.

Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K. Grossmann C, et al. BMC Immunol. 2009 Aug 3;10:43. doi: 10.1186/1471-2172-10-43. BMC Immunol. 2009. PMID: 19650904 Free PMC article.

Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.

Stone GW, Barzee S, Snarsky V, Santucci C, Tran B, Langer R, Zugates GT, Anderson DG, Kornbluth RS. Stone GW, et al. PLoS One. 2009 Oct 8;4(10):e7334. doi: 10.1371/journal.pone.0007334. PLoS One. 2009. PMID: 19812695 Free PMC article.

Regression of established AB1 murine mesothelioma induced by peritumoral injections of CpG oligodeoxynucleotide either alone or in combination with poly(I:C) and CD40 ligand plasmid DNA.

Stone GW, Barzee S, Snarsky V, Santucci C, Tran B, Kornbluth RS. Stone GW, et al. J Thorac Oncol. 2009 Jul;4(7):802-8. doi: 10.1097/JTO.0b013e3181a8634d. J Thorac Oncol. 2009. PMID: 19550243 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters